NCT06092320 Does Teaching Before or After Simulation Improve Learning?
| NCT ID | NCT06092320 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of British Columbia |
| Condition | Medical Education |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2023-09-20 |
| Primary Completion | 2025-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2023-09-20 with a primary completion date of 2025-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of the randomized educational intervention study is to test whether simulation preceding didactic teaching leads to improved knowledge and performance retention compared to a didactic lecture proceeding simulation for medical students Participants will be randomized to one of two different groups with reverse orders for simulation and lectures. Researchers will compare each group to see which way is better for learning.
Eligibility Criteria
Inclusion Criteria: \- Second year medical student at the University of British Columbia Exclusion Criteria: \- None
Contact & Investigator
Melissa Chan, MD
PRINCIPAL INVESTIGATOR
Provincial Health Services Authority British Columbia
Frequently Asked Questions
Who can join the NCT06092320 clinical trial?
This trial is open to participants of all sexes, studying Medical Education. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06092320 currently recruiting?
Yes, NCT06092320 is actively recruiting participants. Contact the research team at john.ramsay1@phsa.ca for enrollment information.
Where is the NCT06092320 trial being conducted?
This trial is being conducted at Vancouver, Canada.
Who is sponsoring the NCT06092320 clinical trial?
NCT06092320 is sponsored by University of British Columbia. The principal investigator is Melissa Chan, MD at Provincial Health Services Authority British Columbia. The trial plans to enroll 40 participants.